LivaNova Plc (LIVN)

63.16 -0.72 (-1.13%) USD  |  NASDAQ  |  Jan 23, 16:00
63.46 +0.30 (+0.47%) After-Hours: 20:00
More

LivaNova Research and Development Expense (TTM): 176.94M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for LIVN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
NovoCure Ltd. 214.85M
Abbott Laboratories 2.89B
Alphatec Holdings, Inc. 76.78M
AtriCure, Inc. 89.62M
iRhythm Holdings, Inc. 82.64M